Flunisyn, advanced development of a synthetic universal influenza T-cell vaccine

Flunisyn, advanced development of a synthetic universal influenza T-cell vaccine Dr Campbell Bunce, Research & Development Director, ITS Innovation Despite significant leaps in Influenza treatment and prevention, there is still a significant unmet need. There is now heightened risk against new and more virulent influenza strains, as well as the continuing rish of pandemic remains, which a major threat to …